Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor.
Stamos, J., Sliwkowski, M.X., Eigenbrot, C.(2002) J Biol Chem 277: 46265-46272
- PubMed: 12196540 
- DOI: 10.1074/jbc.M207135200
- Primary Citation of Related Structures:  
1M14, 1M17 - PubMed Abstract: 
The crystal structure of the kinase domain from the epidermal growth factor receptor (EGFRK) including forty amino acids from the carboxyl-terminal tail has been determined to 2.6-A resolution, both with and without an EGFRK-specific inhibitor currently in Phase III clinical trials as an anti-cancer agent, erlotinib (OSI-774, CP-358,774, Tarceva(TM)) ...